Alenazi, T.A.; Shaman, M.S.B.; Suliman, D.M.; Alanazi, T.A.; Altawalbeh, S.M.; Alshareef, H.; Lahreche, D.I.; Al-Azzam, S.; Araydah, M.; Karasneh, R.;
et al. The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection. Healthcare 2023, 11, 487.
https://doi.org/10.3390/healthcare11040487
AMA Style
Alenazi TA, Shaman MSB, Suliman DM, Alanazi TA, Altawalbeh SM, Alshareef H, Lahreche DI, Al-Azzam S, Araydah M, Karasneh R,
et al. The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection. Healthcare. 2023; 11(4):487.
https://doi.org/10.3390/healthcare11040487
Chicago/Turabian Style
Alenazi, Thamer A., Maryam S. Bin Shaman, Durria M. Suliman, Turkiah A. Alanazi, Shoroq M. Altawalbeh, Hanan Alshareef, Doha I. Lahreche, Sayer Al-Azzam, Mohammad Araydah, Reema Karasneh,
and et al. 2023. "The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection" Healthcare 11, no. 4: 487.
https://doi.org/10.3390/healthcare11040487
APA Style
Alenazi, T. A., Shaman, M. S. B., Suliman, D. M., Alanazi, T. A., Altawalbeh, S. M., Alshareef, H., Lahreche, D. I., Al-Azzam, S., Araydah, M., Karasneh, R., Rebahi, F., Alharbi, M. H., & Aldeyab, M. A.
(2023). The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection. Healthcare, 11(4), 487.
https://doi.org/10.3390/healthcare11040487